| Megan Schneider, | |
|
29 N Academy St, Greenville, SC 29601-2629 | |
| (864) 331-1350 | |
| Not Available |
| Full Name | Megan Schneider |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 29 N Academy St, Greenville, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043701709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP.6271SLP (South Carolina) | Secondary |
| 235Z00000X | Speech-language Pathologist | 6271 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Schneider, 1 Independence Pt Ste 212, Greenville, SC 29615-4536 Ph: (864) 797-6308 | Megan Schneider, 29 N Academy St, Greenville, SC 29601-2629 Ph: (864) 331-1350 |
News Archive
"In the end, we couldn't connect. Not because of different personalities, but because of different visions for our country," Boehner said in a letter to colleagues. He said Mr. Obama "is emphatic that taxes have to be raised" and "adamant that we cannot make fundamental changes to our entitlement programs."
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
The COVID-19 pandemic and resulting stay-at-home orders have taken a toll on many facets of physical and mental health in recent months. But according to new University of Colorado Boulder research, one silver lining may exist.
Overall alcohol use-particularly consumption of beer-is declining in the US, according to a new study published in the August 2008 issue of The American Journal of Medicine.
MannKind Corporation today announced the pricing of its previously announced offering of $100 million aggregate principal amount of Senior Convertible Notes due 2015 (the "Notes"). The Notes will be offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), by the financial institutions that are the initial purchasers of the notes.
› Verified 4 days ago
Kaitlyn Ashley Fencik, M.A. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Prado Way, Greenville, SC 29607 Phone: 732-608-4098 | |
Mrs. Mary Carolyn Gilkinson, MSR, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 N Academy St, Greenville, SC 29601 Phone: 864-331-1380 | |
Andrea L. Murdock, S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 N Academy St, Greenville, SC 29601 Phone: 864-331-1350 | |
Kyler Meredith Evans, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Brendan Way, Greenville, SC 29615 Phone: 864-775-6685 Fax: 864-551-4440 | |
Olivia Catherine Bair, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Griffith Rd, Greenville, SC 29607 Phone: 864-990-1918 | |
Kaley Sanford Jennings, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Augusta St, Greenville, SC 29605 Phone: 864-370-0131 | |
Rachel Walker, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Pelham Ridge Dr, Greenville, SC 29615 Phone: 864-627-5097 Fax: 864-627-5099 |